Medicamen Biotech Limited has informed the Exchange regarding Board meeting held on April 24, 2025. Revised Outcome
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech Limited has filed a revised outcome of its Board meeting held on April 24, 2025, with the stock exchanges (NSE). The original filing has been updated. No specific decisions, financial figures, or resolutions are mentioned in the available filing text. Investors should check the full revised document for details on what the Board discussed or approved, which could range from financial results to fundraising, expansions, or other corporate actions.
The revised filing may indicate a correction or update to an earlier announcement, but without specific details, the exact impact on shareholders is unclear. Investors should review the full revised outcome to understand any changes that could affect the stock or company strategy.